Astragaloside IV from Astragalus membranaceus Fisch. ex Bunge Mitigates DSS-Induced Colitis via Anti-Inflammatory and Antioxidant Modulation of the Gut–Liver–Brain Axis
Antioxidants · 10.04.2026 · 15 (4) · 474
DOI: 10.3390/antiox15040474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.04.2026. Verfasst von Woo-Gyun Choi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Yangsan 50612, Republic of Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TBasic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education., Basic Science Research Program.
Abstract (Originalsprache)
Background
Astragalus membranaceus Fisch. ex Bunge has long been used in East Asian medicine for gastrointestinal disorders and immune modulation. Astragaloside IV (AS-IV), a major bioactive saponin from its roots, exhibits potent anti-inflammatory and antioxidant activities, yet its protective effects against inflammatory bowel disease (IBD)-associated multi-organ damage via the gut–liver–brain axis remain unclear.
Methods
Experimental colitis was induced in C57BL/6N mice by administering 5% dextran sulfate sodium (DSS) in drinking water for seven days. AS-IV (100 mg/kg/day) was orally administered during DSS exposure. Disease severity was evaluated using body weight, colon length, disease activity index, and histopathology. Inflammatory cytokines and oxidative stress markers were measured using ELISA, and NF-κB and MAPK signaling were analyzed through Western blotting and immunohistochemistry in colonic, hepatic, and brain tissues.
Results
AS-IV significantly alleviated DSS-induced weight loss, disease activity, and colon shortening, while improving intestinal histopathological damage. AS-IV also reduced systemic pro-inflammatory cytokine levels and oxidative stress. Mechanistically, AS-IV was associated with a reduced expression of phosphorylated NF-κB and MAPK proteins, including p-NF-κB, p-IκBα, p-ERK, p-JNK, and p-p38, across the colon, liver, and brain.
Conclusions
AS-IV attenuates DSS-induced multi-organ inflammation via gut–liver–brain axis modulation through NF-κB and MAPK pathway inhibition in experimental colitis models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Yangsan 50612, Republic of Korea.
ORCID-Profile: Woo-Gyun Choi
Förderung
- TBasic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education.
- Basic Science Research Program
Zitieren
APA
Choi, W. G., & Kim, B. J. (2026). Astragaloside IV from Astragalus membranaceus Fisch. ex Bunge Mitigates DSS-Induced Colitis via Anti-Inflammatory and Antioxidant Modulation of the Gut–Liver–Brain Axis. Antioxidants, 15(4), 474. https://doi.org/10.3390/antiox15040474
Vancouver
Choi WG, Kim BJ. Astragaloside IV from Astragalus membranaceus Fisch. ex Bunge Mitigates DSS-Induced Colitis via Anti-Inflammatory and Antioxidant Modulation of the Gut–Liver–Brain Axis. Antioxidants. 2026;15(4):474. doi:10.3390/antiox15040474
BibTeX
@article{Choi2026,
author = {Choi, Woo-Gyun and Kim, Byung Joo},
title = {Astragaloside IV from Astragalus membranaceus Fisch. ex Bunge Mitigates DSS-Induced Colitis via Anti-Inflammatory and Antioxidant Modulation of the Gut–Liver–Brain Axis},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {474},
doi = {10.3390/antiox15040474}
}
EUVIMED